Fidelity Top Stories
Novartis inks deal to help Pfizer-BioNTech ramp up output of Covid-19 vaccine
Switzerland's Novartis AG has inked a deal with Pfizer-BioNTech aimed at boosting the world's output of Covid-19 vaccines.
BofA sees 'correction' ahead in stockmarkets
Strategists at Bank of America are anticipating a 'correction' in global stockmarkets over the next few months but within the context of more enduring changes in the backdrop for financial markets.
US SEC warns market participants to follow rules, warns on volatility
America's stockmarket regulator warned of the possible fallout from the recent sharp volatility in the share prices of smaller firms.
UK grants Hong Kong citizens route to British passports
Britain on Friday announced it would be offering Hong Kong citizens a route to citizenship but China said it would no longer recognise special British passports.
Facebook shuts Robinhood Stock Traders group amid Wall Street chaos
Facebook closed down a Wall Street discussion group on its platform, Robinhood Stock Traders, amid the frenzy around GameStop shares on Wall Street.
Novavax Covid-19 vaccine nearly 90 per cent effective, less so in South Africa
Novavax's Covid-19 vaccine candidate achieved a very high efficacy, the results of the company's late-stage clinical trials showed.
Germany recommends AstraZeneca vaccine only for use in those under 65 years
German health officials recommended only administering the Covid-19 vaccine developed by AstraZeneca and Oxford University to people under the age of 65, citing "insufficient data".
Interactive Brokers and Robinhood raise margin requirements for trading in GameStop
Two large online trading platforms moved to limit trading in shares of GameStop and other companies that had been caught up in the recent 'melt-up' in their share prices.
US gross domestic product continued to expand in Q4, as expected
America's economy continued expanding at the tail-end of 2020 with economists anticipating that the rebound from the Covid-19 crisis was set to continue.
GameSpot avalanche continues
The dizzying rise of GameStop shares continued on Thursday as fresh investors continued to pile in and - possibly - as more hedge funds opted to 'throw in the tunnel'. Gamestonk!! https://t. co/RZtkDzAewJ — Elon Musk (@elonmusk) January 26, 2021.
Lidl swings to FY loss on store expansion, hiring spree
German discount supermarket Lidl’s UK unit on Thursday reported a sharp full-year loss after investing in staff and logistics.
Britvic Q1 revenues fall as Covid curbs hit in-store sales
UK soft-drinks maker Britvic reported a fall in first quarter revenue as the coronavirus pandemic hit its out-of-home sales, with a rise in home consumption failing to make up the shortfall.
Europe close: Stocks walloped by lockdown blues
European shares were lower on Wednesday as investors held fire ahead of a US Federal Reserve decision on policy later in the day and a row between AstraZeneca and the EU over Covid-19 vaccine supply dampened sentiment.
IMF warns of heightened risks from slow rollout of vaccines in developing countries
The world's financial stability watchdog warned governments that emergency economic measures needed to be retained in order to stave off the risk of a "correction" in stock markets.
Two-thirds of people want action against climate change - UN global poll
Two-thirds of people around the world believe climate change is a global emergency and seek action, revealed a global survey carried out by the United Nations.
EDF delays start of UK Hinkley Point nuclear plant
French energy company EDF said the launch of its Hinkley Point C nuclear plant project in Britain would be delayed until June 2026 as it also lifted cost forecasts.
Fresnillo sees lower 2021 gold output as FY production down 12%
Precious metals miner Fresnillo lowered its current-year gold output forecast as a landslip at its Noche Buena mine and Covid restrictions hit 2020 production.
Pfizer to deliver more Covid-19 vaccine doses to US
The US will receive more Covid-19 vaccine doses from Pfizer and BioNTech and more quickly than expected.
Regeneron Pharmaceuticals Covid-19 antibodies 100% effective in blocking infections
Regeneron Pharmaceuticals antibody cocktail severely curtails Covid-19 symptoms and infections, the results of a late-stage trial showed.
Shortage of construction materials could delay UK housebuilding
An increasing shortage of construction materials in Britain is set to delay housebuilding in 2021.